Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Equillium, Inc. - Common Stock (NQ:EQ)

1.540 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Equillium, Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
Equillium to Present at Two Upcoming Investor Conferences
From Equillium, Inc.
Via Business Wire
News headline image
Equillium Presents Clinical Data from EQUALISE Phase 1b Study in Lupus Patients at the American Society of Nephrology Annual Meeting
From Equillium, Inc.
Via Business Wire
News headline image
Equillium Presents Interim Safety Data from First Cohort of Asthma Patients in Phase 1b EQUIP Study at the American College of Allergy, Asthma & Immunology Meeting
From Equillium, Inc.
Via Business Wire
News headline image
Equillium Announces Two Abstracts Accepted for Presentation at the 63rd ASH Annual Meeting and Exposition
From Equillium, Inc.
Via Business Wire
News headline image
Equillium Announces Interim Safety Data and Reduction in Proteinuria for Lupus Patients Treated with Itolizumab in the EQUALISE Study Presented at the ACR Annual Meeting
From Equillium, Inc.
Via Business Wire
News headline image
Equillium Announces Two Abstracts Accepted for Presentation at the Upcoming Virtual 2021 American Society of Nephrology Annual Meeting
From Equillium, Inc.
Via Business Wire
News headline image
Equillium Announces Multiple Abstracts Accepted for Presentation at ACR Convergence 2021
From Equillium, Inc.
Via Business Wire
News headline image
Equillium to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
From Equillium, Inc.
Via Business Wire
News headline image
Equillium to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
From Equillium, Inc.
Via Business Wire
News headline image
Equillium Announces Update to EQUALISE Study of Itolizumab in Patients with Systemic Lupus Erythematosus and Lupus Nephritis
From Equillium, Inc.
Via Business Wire
News headline image
Equillium Reports Second Quarter 2021 Financial Results and Provides Clinical Development Update
From Equillium, Inc.
Via Business Wire
News headline image
Equillium to Present at the BTIG Virtual Biotechnology Conference
From Equillium, Inc.
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.